Cargando…
Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global pandemic. However, the majority of currently available data are restricted to laboratory-confirmed cases for symptomatic patients, and the SARS-CoV-2 infectio...
Autores principales: | Lai, Chih-Cheng, Wang, Jui-Hsiang, Hsueh, Po-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546669/ https://www.ncbi.nlm.nih.gov/pubmed/33045429 http://dx.doi.org/10.1016/j.ijid.2020.10.011 |
Ejemplares similares
-
Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003
por: Tseng, Wen-Pin, et al.
Publicado: (2021) -
SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline
por: Bolotin, Shelly, et al.
Publicado: (2021) -
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021) -
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021) -
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
por: Naranbhai, Vivek, et al.
Publicado: (2020)